Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bone Growth Stimulators Pipeline Market Report Overview

Bone growth stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures or fusions. They apply electrical or ultrasound waves to the site of the fracture or fusion.

The bone growth stimulators pipeline market research report provides comprehensive information about the bone growth stimulators pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Implantable Bone Growth Stimulators

·       External Bone Growth Stimulators

Key Territories ·       The US

·       Europe

·       Canada

·       Australia

·       Brazil

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       MDL

·       ANVISA

·       TGA

Leading Companies ·       Bionext Biotech Products Ltd.

·       Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine

·       Curative Biosciences, Inc.

·       DJO Global Inc

·       Eepta Pty Ltd

·       GreenBone Ortho srl

·       Inion Oy

·       Johns Hopkins University

·       KeraCure, Inc. (Inactive)

·       Lattice Biologics Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Bone Growth Stimulators Pipeline Market by Segments

The key segments in the bone growth stimulators market are implantable bone growth stimulators and external bone growth stimulators. As of July 2023, implantable bone growth stimulator has a higher number of pipeline products. They are the stimulation devices that are implanted during surgery to stabilize the fracture. External bone growth stimulators are worn outside the skin and do not require any surgical procedure.

Bone Growth Stimulators Pipeline Market Analysis by Segments, 2023 (%)

Bone Growth Stimulators Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the bone growth stimulators pipeline market, download a free report sample

Bone Growth Stimulators Pipeline Market Segmentation by Territories

Some of the key territories in the bone growth stimulators market are the US, Europe, Canada, Australia, and Brazil. As of July 2023, the US has the highest number of pipeline products.

Bone Growth Stimulators Pipeline Market Analysis by Territories, 2023 (%)

Bone Growth Stimulators Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the bone growth stimulators pipeline market, download a free report sample

Bone Growth Stimulators Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the bone growth stimulators pipeline market are 510(k), CE, PMA, MDL, ANVISA, and TGA. As of July 2023, 510(k) is the most followed pathway for pipeline products in the market.

Bone Growth Stimulators Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Bone Growth Stimulators Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the bone growth stimulators pipeline market, download a free report sample

Bone Growth Stimulators Pipeline Market – Competitive Landscape

Some of the key companies in the bone growth stimulators pipeline market are DJO Global Inc, Inion Oy, Bionext Biotech Products Ltd., Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine, Curative Biosciences, Inc., Eepta Pty Ltd, GreenBone Ortho srl, Johns Hopkins University, KeraCure, Inc. (Inactive), and Lattice Biologics Ltd.

DJO Global Inc: It is a medical device company that manufactures and distributes medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. The company’s products include rigid and soft orthopedic bracing, bone growth stimulators, and hot and cold therapy, among others. DJO is headquartered in Lewisville, Texas, the US.

Inion Oy: It is a medical device company that develops biodegradable and bioactive implants. The company offers products that are used in specialty orthopedics, CMF surgeries, spine surgeries, arthroscopybone grafting, and dental surgery applications, among others. Inion is headquartered in Tampere, Finland.

Leading Bone Growth Stimulators Companies, 2023

Leading Bone Growth Stimulators Companies, 2023

For more company insights into the bone growth stimulators pipeline market, download a free report sample

Segments Covered in the Report

Bone Growth Stimulators Pipeline Market Segments Outlook

  • Implantable Bone Growth Stimulators
  • External Bone Growth Stimulators

Bone Growth Stimulators Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • Australia
  • Brazil

Bone Growth Stimulators Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • MDL
  • ANVISA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Bone Growth Stimulators under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Bone Growth Stimulators and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Bone Growth Stimulators under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Bionext Biotech Products Ltd.
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
Curative Biosciences, Inc.
DJO Global Inc
Eepta Pty Ltd
GreenBone Ortho srl
Inion Oy
Johns Hopkins University
KeraCure, Inc. (Inactive)
Lattice Biologics Ltd
Magle Chemoswed AB
Max Biopharma Inc
NC Biomatrix BV
NDSU Research Foundation
Oklahoma State University
Oligo Medic Inc
Orthocell Ltd
Orthofix Medical Inc
OsteoGenix Incorporated (Inactive)
REGENECURE Ltd
Texas A&M University
The University of Nottingham
Universiti Putra Malaysia
University of California Davis
University of Florida
University of Wisconsin Madison
Wright Medical Group NV (Inactive)
ZetaGen Therapeutics Inc
ZimVie Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Bone Growth Stimulators Overview

  • 3 Products under Development

    • 3.1 Bone Growth Stimulators – Pipeline Products by Stage of Development
    • 3.2 Bone Growth Stimulators – Pipeline Products by Segment
    • 3.3 Bone Growth Stimulators – Pipeline Products by Territory
    • 3.4 Bone Growth Stimulators – Pipeline Products by Regulatory Path
    • 3.5 Bone Growth Stimulators – Pipeline Products by Estimated Approval Date
    • 3.6 Bone Growth Stimulators – Ongoing Clinical Trials

  • 4 Bone Growth Stimulators – Pipeline Products under Development by Companies

    • 4.1 Bone Growth Stimulators Companies – Pipeline Products by Stage of Development
    • 4.2 Bone Growth Stimulators – Pipeline Products by Stage of Development

  • 5 Bone Growth Stimulators Companies and Product Overview

    • 5.1 Bionext Biotech Products Ltd. Company Overview

      • 5.1.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview

      • 5.2.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Curative Biosciences, Inc. Company Overview

      • 5.3.1 Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 DJO Global Inc Company Overview

      • 5.4.1 DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Eepta Pty Ltd Company Overview

      • 5.5.1 Eepta Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 GreenBone Ortho srl Company Overview

      • 5.6.1 GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Inion Oy Company Overview

      • 5.7.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Johns Hopkins University Company Overview

      • 5.8.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 KeraCure, Inc. (Inactive) Company Overview

      • 5.9.1 KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Lattice Biologics Ltd Company Overview

      • 5.10.1 Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Magle Chemoswed AB Company Overview

      • 5.11.1 Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Max Biopharma Inc Company Overview

      • 5.12.1 Max Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 NC Biomatrix BV Company Overview

      • 5.13.1 NC Biomatrix BV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 NDSU Research Foundation Company Overview

      • 5.14.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Oklahoma State University Company Overview

      • 5.15.1 Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Oligo Medic Inc Company Overview

      • 5.16.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Orthocell Ltd Company Overview

      • 5.17.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Orthofix Medical Inc Company Overview

      • 5.18.1 Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 OsteoGenix Incorporated (Inactive) Company Overview

      • 5.19.1 OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 REGENECURE Ltd Company Overview

      • 5.20.1 REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Texas A&M University Company Overview

      • 5.21.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 The University of Nottingham Company Overview

      • 5.22.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Universiti Putra Malaysia Company Overview

      • 5.23.1 Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 University of California Davis Company Overview

      • 5.24.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 University of Florida Company Overview

      • 5.25.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 University of Wisconsin Madison Company Overview

      • 5.26.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Wright Medical Group NV (Inactive) Company Overview

      • 5.27.1 Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 ZetaGen Therapeutics Inc Company Overview

      • 5.28.1 ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 ZimVie Inc Company Overview

      • 5.29.1 ZimVie Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Bone Growth Stimulators- Recent Developments

    • 6.1 May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update
    • 6.2 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • 6.3 May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report
    • 6.4 Apr 27, 2023: Integer Holdings reports First Quarter 2023 results
    • 6.5 Apr 19, 2023: Anika to issue first quarter 2023 financial results on Tuesday, may 9, 2023
    • 6.6 Apr 12, 2023: Medtronic has a layoff in California
    • 6.7 Mar 31, 2023: Bioventus announces Q4 and full-year 2022 financial results
    • 6.8 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
    • 6.9 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
    • 6.10 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.11 Mar 06, 2023: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
    • 6.12 Feb 21, 2023: Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
    • 6.13 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
    • 6.14 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings
    • 6.15 Feb 09, 2023: Spineway announces 2022 annual results
    • 6.16 Dec 01, 2022: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
    • 6.17 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.18 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.19 Nov 21, 2022: Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
    • 6.20 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.21 Nov 08, 2022: Anika Reports Third Quarter Fiscal 2022 Financial Results
    • 6.22 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results
    • 6.23 Oct 25, 2022: Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
    • 6.24 Oct 11, 2022: Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
    • 6.25 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.26 Aug 25, 2022: Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
    • 6.27 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.28 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.29 Aug 11, 2022: Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
    • 6.30 Aug 09, 2022: Kuros Biosciences reports results for the first six months of 2022
    • 6.31 Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results
    • 6.32 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results
    • 6.33 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results
    • 6.34 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Bone Growth Stimulators – Pipeline Products by Stage of Development 11

Bone Growth Stimulators – Pipeline Products by Segment 12

Bone Growth Stimulators – Pipeline Products by Territory 13

Bone Growth Stimulators – Pipeline Products by Regulatory Path 14

Bone Growth Stimulators – Pipeline Products by Estimated Approval Date 15

Bone Growth Stimulators – Ongoing Clinical Trials 16

Bone Growth Stimulators Companies – Pipeline Products by Stage of Development 17

Bone Growth Stimulators – Pipeline Products by Stage of Development 19

Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

Orthonext – Product Status 20

Orthonext – Product Description 20

Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 21

Bioactive Glass Scaffold – Product Status 21

Bioactive Glass Scaffold – Product Description 21

Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Nurture BSP – Product Status 22

Nurture BSP – Product Description 22

Osteoconductive Scaffold – Product Status 23

Osteoconductive Scaffold – Product Description 23

DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview 24

CMF OL1000 – Fresh Ankle Fracture – Product Status 24

CMF OL1000 – Fresh Ankle Fracture – Product Description 24

DJO Global Inc – Ongoing Clinical Trials Overview 25

CMF OL1000 – Fresh Ankle Fracture – Prospective, Randomized, Double-blinded, Controlled Multi-center Clinical Trial Evaluating the Use of Non-invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures 26

Eepta Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Bone Growth Scaffold – Product Status 27

Bone Growth Scaffold – Product Description 27

GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview 28

b.Bone Implant – Product Status 28

b.Bone Implant – Product Description 28

GreenBone Ortho srl – Ongoing Clinical Trials Overview 29

b.Bone Implant – A Pre-market Multicenter National Open Label Single Arm Study to Evaluate the Safety and Performance of a Class III Medical Device (Greenbone Implant) for Iliac Crest Reconstruction Following Bone Graft Harvesting for Pelvic Fusion 30

b.Bone Implant – A Pre-market, Multi-center, International, Open-label, Single-arm Study to Evaluate the Safety and Performance of a Class III Medical Device (GreenBone Implant) for Surgical Repair of Long Bone Defects 30

b.Bone Implant – A Pre-market, Open-label, Single-arm Study to Evaluate b.Bone for Posterolateral Fusion Treatment of Degenerative Thoracolumbar, Lumbar or Lumbosacral Spinal Disease (b.Spine Clinical Trial). 30

Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 31

Inion Optimaplus – Product Status 31

Inion Optimaplus – Product Description 31

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 32

3D-printed Bone Extracellular Matrix Scaffold – Product Status 32

3D-printed Bone Extracellular Matrix Scaffold – Product Description 32

KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

KeraPac – Bone Regeneration – Product Status 33

KeraPac – Bone Regeneration – Product Description 33

Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Bone Scaffold + ECM – Product Status 34

Bone Scaffold + ECM – Product Description 34

Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview 35

SmartBone – Product Status 35

SmartBone – Product Description 35

Max Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Oxy133 Implantable Device – Product Status 36

Oxy133 Implantable Device – Product Description 36

NC Biomatrix BV Pipeline Products & Ongoing Clinical Trials Overview 37

Vitadisc – Product Status 37

Vitadisc – Product Description 37

NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 38

Bone Scaffold – Product Status 38

Bone Scaffold – Product Description 38

Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview 39

Bone Repair Scaffold – Product Status 39

Bone Repair Scaffold – Product Description 39

Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 40

BoneRep – Product Status 40

BoneRep – Product Description 40

Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

CelGro SMRT Graft – Bone Repair – Product Status 41

CelGro SMRT Graft – Bone Repair – Product Description 41

Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Cervical-Stim Osteogenesis Stimulator – Odontoid Fractures – Product Status 42

Cervical-Stim Osteogenesis Stimulator – Odontoid Fractures – Product Description 42

Physio-Stim Osteogenesis Stimulator – Osteoarthritis – Product Status 43

Physio-Stim Osteogenesis Stimulator – Osteoarthritis – Product Description 43

RCStim Device – Product Status 43

RCStim Device – Product Description 44

Orthofix Medical Inc – Ongoing Clinical Trials Overview 45

RCStim Device – Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears 46

OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

Bone Anabolic Agent – Product Status 47

Bone Anabolic Agent – Product Description 47

REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Regenecure AMCA GBR Bone Membrane Implant – Product Status 48

Regenecure AMCA GBR Bone Membrane Implant – Product Description 48

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 49

Bioactive Foam Based Moldable Scaffold – Product Status 49

Bioactive Foam Based Moldable Scaffold – Product Description 49

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 50

Injectable Bone – Product Status 50

Injectable Bone – Product Description 50

Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview 51

Nanocomposite Bone Scaffold – Product Status 51

Nanocomposite Bone Scaffold – Product Description 51

University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 52

Synthetic Bone Matrix – Product Status 52

Synthetic Bone Matrix – Product Description 52

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 53

Bone Tissue Scaffold – Product Status 53

Bone Tissue Scaffold – Product Description 53

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 54

Fracture Electrostimulation Device – Product Status 54

Fracture Electrostimulation Device – Product Description 54

Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

Soft Tissue Graft – Product Status 55

Soft Tissue Graft – Product Description 55

ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Nalovent Bone Graft – Product Status 56

Nalovent Bone Graft – Product Description 56

ZetaMet – Product Status 57

ZetaMet – Product Description 57

ZetaGen Therapeutics Inc – Ongoing Clinical Trials Overview 58

ZetaMet – Feasibility Study of ZetaFuse Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body 59

ZimVie Inc Pipeline Products & Ongoing Clinical Trials Overview 60

OrthoPak III – Product Status 60

OrthoPak III – Product Description 60

Glossary 108

Figures

Bone Growth Stimulators – Pipeline Products by Stage of Development 11

Bone Growth Stimulators – Pipeline Products by Segment 12

Bone Growth Stimulators – Pipeline Products by Territory 13

Bone Growth Stimulators – Pipeline Products by Regulatory Path 14

Bone Growth Stimulators – Pipeline Products by Estimated Approval Date 15

Bone Growth Stimulators – Ongoing Clinical Trials 16

Frequently asked questions

Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Bone Growth Stimulators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.